United States Kidney Function Test Market is Expected to be Dominated by Urine Tests through 2028
During the forecast period,
2024–2028, growing incidences of chronic kidney disorders is expected to fuel
market expansion in the United States kidney function test market.
According to TechSci Research
report, “United States Kidney Function Test - By Region, Competition,
Forecast and Opportunities, 2028”, The United States kidney function tests
market has been increasing substantially in recent years due to several
factors, including the increasing incidence of chronic kidney diseases and
growing public awareness of early detection. The rising incidence of chronic
renal diseases in the United States is one of the major market drivers.
Kidney problems are on the rise and are influenced by illnesses including
diabetes, hypertension, and obesity. As a result, there is an increased need
for kidney function tests to evaluate renal health, identify kidney diseases,
and track the development of diseases. The market of kidney function tests is
expanding due to the rising number of patients with chronic kidney diseases.
The increasing awareness of the
significance of early kidney diagnosis is another factor operating the market.
The significance of routine kidney function testing as a component of routine
health examinations is being emphasised by medical professionals and
organisations. Early detection allows for prompt management, timely
intervention, and better patient outcomes. More people are also requesting
kidney function tests to evaluate their renal health because of greater
awareness among people of the risk factors and symptoms of kidney disease.
The precision and rapidity of
diagnostic results have increased due to new technology like automated
analysers, point-of-care testing equipment, and novel biomarkers. Kidney
function tests are now simpler for patients to obtain and more feasible, which
has increased operation. Additionally, using machine learning and artificial
intelligence into test interpretation has the potential to improve diagnostic
precision and effectiveness.
The United States kidney function
tests market has been severely affected by the COVID-19 pandemic. Healthcare
systems were impacted during the pandemic, which caused delays in routine
medical exams and operations. The number of renal function tests conducted
during the early stages of the pandemic consequently significantly decreased.
However, there is an increase in demand for these tests as things have
gradually gotten back to normal. Due to the increased risk of serious COVID-19
problems in those with pre-existing kidney ailments, the pandemic has also
brought attention to the significance of renal health.
Browse over XX Market Data
Figures spread through XX Pages and an in-depth TOC on "United States Kidney Function Test Market."
The United States kidney function
test market can be segmented by type, component, end user, and region.
Based on type, the market can be
segmented into urine tests and blood tests. In the years to come, urine tests
are expected to dominate the growth of the kidney function test market in the
United States for several of key factors. Urine tests provide a handy and a
non-invasive method to evaluate kidney function, making them accessible and
less terrifying for patients. This aspect of convenience encourages patient
compliance and testing willingness. Furthermore, through assessing a variety of
markers like albumin, creatinine, and other chemicals, urine tests offer a
thorough evaluation of kidney health. This precision enables the identification
of abnormalities and the evaluation of ailments like proteinuria or hematuria.
Additionally, urine tests are very helpful in the early detection of kidney
conditions, allowing for rapid management and intervention.
In terms of component, the market
can be divided into dipsticks, reagents, kits & assays, and others. Due to
several factors, kits and assays are expected to dominate the growth of the
kidney function test market in the United States in the years to come. Kidney
function testing can be performed in a standardized and effective way using
kits and assays. These ready-to-use kits include all necessary reagents and
materials, simplifying the testing procedure and reducing the risk of mistakes.
The precision and dependability of outcomes from tests are enhanced by
standardization, making them an appealing option for healthcare professionals.
Convenience and effectiveness are offered through kits and assays. Medical
professionals can conduct tests quickly and easily with pre-packaged kits and
assays, saving time and resources. In high-volume situations like hospitals and
laboratories, this efficiency is especially beneficial.
Based on the region, the market
can be classified into the following categories, North-East, Mid-West, South,
and West. In the years to come, the United States kidney function is expected
to increase most dramatically in the North-east of the United States for
several of factors. The factor contributing to the greater incidence of renal
problems in the region is the high prevalence of associated risk factors for
kidney disease such hypertension, diabetes, and obesity. There are more elderly
individuals living in the area, who are more likely to have kidney disease. In
the North-east, there is a higher percentage of those over 65, who are more
likely to need renal function tests. The region is home to numerous
universities, medical centres, and research facilities, giving access to
cutting-edge equipment and expertise in the diagnosis and treatment of renal
disease.
Major companies operating in United States kidney function
test market include:
- Abbott Laboratories
- Quest Diagnostics
- LabCorp
- Hoffmann-La Roche Ltd
- Bio-Rad Laboratories, Inc.
- Sysmex Corporation
Download Free Sample Report
Customers can also request
for 10% free customization on this report.
“The United States kidney
function tests market is growing significantly due to several factors. The
need for kidney function tests is being driven by a rise in the prevalence of
chronic kidney diseases, increased awareness of early detection, and an
increasing emphasis on preventive healthcare. However, there are challenges in
the market, such as limited access to healthcare facilities in certain regions
and high costs for testing. There are many companies operating in the market,
including significant competitors like Siemens Healthineers, LabCorp, and Quest
Diagnostics. The integration of automated analyzers, point-of-care testing
equipment, and artificial intelligence algorithms has transformed kidney
function testing. The market is dominated by diagnostic laboratories due to
their expertise, resources, and wide range of test options.” said Mr. Karan
Chechi, Research Director with TechSci Research, a research-based global
management consulting firm.
“United States Kidney Function
Test Market, By Type (Urine Tests and Blood Tests), By Component (Dipsticks,
Reagents, Kits & Assays, Others), By End User (Hospitals & Clinics,
Diagnostic Laboratories, Others), By Region, Competition Forecast &
Opportunities, 2028”, has evaluated the future growth potential of United
States kidney function test market and provides statistics & information on
market size, structure, and future market growth. The report intends to provide
cutting-edge market intelligence and help decision makers take sound investment
decisions. Besides, the report also identifies and analyzes the emerging trends
along with essential drivers, challenges, and opportunities in United States
kidney function test market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]
Website: https://www.techsciresearch.com